Skip to content

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

biosimilar

Dong-A ST, 1,000 won cash dividend per common stock

Dong-A ST, 1,000 won cash dividend per common stock

Samsung Bioepis selected Yuhan Corporation as a domestic sales company of Humira’s biosimilar’Adaloce’

Samsung Bioepis selected Yuhan Corporation as a domestic sales company of Humira’s biosimilar’Adaloce’

MEDI:GATE NEWS Samsung Bioepis and Yuhan Corporation signed a domestic sales partnership with Humira biosimilar adaloce

MEDI:GATE NEWS Samsung Bioepis and Yuhan Corporation signed a domestic sales partnership with Humira biosimilar adaloce

Completed Phase 1 clinical trial of Alteogen’s first Ilia biosimilar in Korea

Completed Phase 1 clinical trial of Alteogen’s first Ilia biosimilar in Korea

Celltrion acquires European sales license for’U Plaima’ …’First high-speed Humira biosimilar’

Celltrion acquires European sales license for’U Plaima’ …’First high-speed Humira biosimilar’

“Global 10th Goal” Listed on Phoebe Pharma…  What are your strengths?

“Global 10th Goal” Listed on Phoebe Pharma… What are your strengths?

“Celltrion, biosimilar developer has exceeded the limit… Performance improvement is’well’”

“Celltrion, biosimilar developer has exceeded the limit… Performance improvement is’well’”

footer

  • Contact Us
  • Sitemap
  • News-Sitemap
© 2025 Aju.News/en